(NASDAQ: SNY) Sanofi's forecast annual revenue growth rate of 7.31% is not forecast to beat the US Drug Manufacturers - General industry's average forecast revenue growth rate of 8.71%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.18%.
Sanofi's revenue in 2025 is $46,131,250,000.On average, 6 Wall Street analysts forecast SNY's revenue for 2025 to be $61,695,954,816,420, with the lowest SNY revenue forecast at $58,110,971,277,782, and the highest SNY revenue forecast at $66,901,749,641,945. On average, 6 Wall Street analysts forecast SNY's revenue for 2026 to be $66,286,294,359,260, with the lowest SNY revenue forecast at $61,518,686,910,632, and the highest SNY revenue forecast at $72,562,762,528,014.
In 2027, SNY is forecast to generate $72,354,006,235,914 in revenue, with the lowest revenue forecast at $68,274,460,890,219 and the highest revenue forecast at $76,471,862,093,737.